The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cross Stefan since 2017.
The trader's CIK number is 1611506.
At the time of the last reporting, Cross Stefan was the Director of Inhibitor Therapeutics, Inc.. (stock ticker symbol INTI).
Also see all insider trading activities at Inhibitor Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | HPPI | 600,000 | $97,596,000,000 | 0 | $0 | 0 | $0 |
| 2017 | HPPI | 0 | $0 | 0 | $0 | 600,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-19 | HPPI | Buy | 600,000 | 162,660.00 | 97,596,000,000 |
| 2017-03-08 | HPPI | Option Ex | 600,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cross Stefan (Director of Inhibitor Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.